You are here: Industry Insights > J&J

News List

J&J chief Gorsky took a big pay hit in 2018 but still nabbed $20M fiercepharma
March 18, 2019
Johnson & Johnson hit—and exceeded—all its financial goals in 2018. So why did its top executive take a $9 million-plus pay cut?
J&J ends 2018 on a high, but coming year looks shaky pharmaphorum
January 24, 2019
Johnson & Johnson (J&J) has kicked off results season with a downbeat forecast for the year as competition to some of its top products starts to have an impact on revenues.
J&J reports 2018 fourth-quarter results biospectrumasia
January 24, 2019
Worldwide sales for the full-year 2018 were $81.6 billion, an increase of 6.7% versus 2017
AbbVie and J&J’s Imbruvica fails pancreatic cancer test pharmaphorum
January 23, 2019
AbbVie and Johnson & Johnson’s hopes of adding pancreatic cancer to the repertoire of oncology blockbuster Imbruvica has hit a snag.
J&J partners with Apple for ECG monitoring project pharmaphorum
January 22, 2019
Apple has a new big pharma partner to help put its new Apple Watch with built-in electrocardiogram (ECG) through its paces, signing an alliance with Johnson & Johnson.
Ribon Therapeutics gains Novartis, J&J backing for monoPARP work fiercebiotech
January 07, 2019
The once highly secretive Ribon Therapeutics has come out with a chunky series B with a focus on monoPARPs against cancer, inflammatory disorders and neurodegenerative diseases.....
ASH18: J&J shells out $500M to sew up Argenyx's blood cancer hopeful cusatuzumab fiercebiotech
January 03, 2019
As the biggest and brightest in the blood cancer world came together for the ASH conference this weekend, European biotech Argenx was busy making a big biobucks deal......
J&J's Baby powder tested in India and Bangladesh pharmafile
December 24, 2018
Bangladeshi authorities will collect and test samples of Johnson & Johnson’s baby powders for traces of cancer causing asbestos, after a Reuter’s report revealed that the company had known
J&J hits back over asbestos in talc claims pharmaphorum
December 18, 2018
Shares in Johnson & Johnson slid around 10% on Friday after a Reuters article claimed the company had known for decades about asbestos in talcum powder products.
J&J says its psoriasis drug superior to Novartis treatment: Study expressbpd
December 14, 2018
Psoriasis is a chronic condition that causes an overproduction of skin cells, resulting in inflamed, red lesions or plaques, which can be itchy and painful

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page